secwatch.observer — SEC 8-K summary
======================================

Issuer:     DANAHER CORP /DE/ (DHR)
CIK:        0000313616
Form:       8-K
Filed at:   2025-10-21T23:59:59+00:00
Accession:  0000313616-25-000180
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Danaher Q3 2025: EPS $1.27 GAAP, $1.89 adjusted; revenue up 4.5% to $6.1B
-------------------------------------------------------------------------

- Net earnings $908M ($1.27 diluted EPS); non-GAAP adjusted diluted EPS $1.89.
- Revenue $6.1B, up 4.5% YoY; non-GAAP core revenue up 3.0% YoY.
- Operating cash flow $1.7B; non-GAAP free cash flow $1.4B.
- Full-year 2025 adjusted diluted EPS guidance maintained at $7.70-$7.80; core revenue expected low-single-digit growth.
- Cepheid respiratory revenue better-than-anticipated; bioprocessing momentum cited as key driver.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313616/000031361625000180/0000313616-25-000180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313616/000031361625000180/dhr-20251021.htm
  HTML page:      https://secwatch.observer/filing/0000313616-25-000180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer